CLINICAL COURSE OF BRONCHIAL ASTHMA IN PATIENTS WITH THYROID DISEASES
##semicolon##
Key words: bronchial asthma, compensated hypothyroidism, compensated thyrotoxicosis, diffuse nodular goiter.##article.abstract##
Bronchial asthma (BA) is one of the most common chronic lung diseases. The
incidence of In Uzbekistan, it varies from 2.6 to 20.3%. This disease is more common
among the urban population and has a more severe course in patients with combined
pathology. Along with AD, thyroid pathology is also a widespread disease. Taking into
account the fact that 20% of the population live in iodine-endemic regions in which
iodine prophylaxis is insufficiently effectively carried out a large part of the population
has an increase in the volume of the thyroid gland. The study assessed the clinical
picture of bronchial asthma by the presence of shortness of breath, attacks of
suffocation, seases. It was noted that the course of bronchial asthma is affected by both
dysfunction and a change in the structure of the thyroid gland, leading to a more severe
course of asthma.
##submission.citations##
1. Ziyadullaev, S. K., Sultonov, I. I., Dushanova, G. A., & Akbarovna, K. S. (2021).
The Effectiveness Of Pharmacotherapy For Dmards With Ra Depending On The
C3435t Polymorphism Of The Mdr1 Gene. Int. J. of Aquatic Science, 12(3), 2908-
2916.
2. Islomovich, S. I. (2024). GENDER CHARACTERISTICS OF THE CURRENT
RHEUMATOID ARTHRITIS. International journal of medical sciences, 4(10), 3-
8.
3. Ilkhom, S. (2023). CAJAM–VOLUME 1. ISSUE 1. 2023. Central Asian Journal
of Advanced Medicine, 1(01), 16-19.
4. Хамраева, Н. А., Султонов, И. И., & Хасанов, Ф. Ш. У. (2019). Кожные
проявления у больных системной красной волчанкой. Вопросы науки и
образования, (28 (77)), 128-131.
5. Sultonov, I. I., Kh, Z. S., Ruzybakieva, M. R., Kireev, V. V., Aripova, T. U., &
Suyarov, A. A. (2021). Pharmacogenetic Aspects of Drug Resistance in
Rheumatoid Arthritis. Annals of the Romanian Society for Cell Biology, 4147-4150.
6. Kireev, V. V., & Sultonov, I. I. (2021). Genetic Engineered Preparations-An
Innovative Approach in the Treatment of Rheumatoid Arthritis. Annals of the
Romanian Society for Cell Biology, 4114-4119.
7. Hamraeva, N. A., Sultonov, I. I., & Hasanov, F. S. (2020). Systemic lupus
erythematosus treatment strategy. Journal of Critical Reviews, 7(9), 269-270.
8. Тоиров, А. Э., Султонов, И. И., & Тоиров, Э. С. (2020). ЗНАЧЕНИЕ
ДИСФУНКЦИИ ПОЧЕК У БОЛЬНЫХ ОСТРЫМ ИНФАРКТОМ
МИОКАРДА НА ФОНЕ САХАРНОГО ДИАБЕТА 2-ГО ТИПА. Вестник
науки и образования, (9-3 (87)), 86-91.
9. Иргашева, У. З., Султонов, И. И., & Тоиров, Д. Р. (2013). Признаки дебюта
системной красной волчанки. Академический журнал Западной Сибири, 9(1),
15-15.
10. Xasanov, F. S., & Sultonov, I. I. (2023). RHEUMATOID ARTHRITIS TREATED
WITH DMARDS AND CARDIOVASCULAR DISEASE RISK. Oriental Journal
of Medicine and Pharmacology, 3(02), 45-52.
11. Нурматова, Л., Султонов, И., & Тоиров, Э. (2011). Эффективность препаратов
пищеварительной активности в комплексном лечении больных хроническим
гепатитом. Журнал проблемы биологии и медицины, (3 (66)), 107-110.
12. Sultonov, I. I., Khamrayev, X. X., & Xasanov, F. SYSTEMIC LUPUS
ERYTHEMATOSUS AND CARDIOVASCULAR PATHOLOGY: WHERE WE
AT?.
13. Sultonov, I. I., Xasanov, F. S., Eshmuratov, S., Uralov, R. S., Shukurova, D., &
Ziyadullayev, S. X. Predictors of Systemic Lupus Erythematosus: A Case-control
Study. International journal of health sciences, 6(S10), 175-182.
14. Nizamitdinovich, K. S., Alisherovna, K. M., & Erkinovna, K. Z. (2024).
ASSESSMENT OF THE RISK OF DEVELOPING DIABETES MELLITUS FOR
MEN. Spectrum Journal of Innovation, Reforms and Development, 26, 114-123.
15. Alisherovna, K. M., Nizamitdinovich, K. S., & Erkinovna, K. Z. (2024). THE
EFFECTIVENESS OF BISOPROLOL AND METFORMIN IN ARTERIAL
HYPERTENSION AND METABOLIC SYNDROME. Spectrum Journal of
Innovation, Reforms and Development, 26, 106-113.
16. Erkinovna, K. Z., Alisherovna, K. M., & Nizamitdinovich, K. S. (2024).
DIABETES MELLITUS AND MENOPAUSE. Spectrum Journal of Innovation,
Reforms and Development, 27, 56-65.
17. Khaydarov, S. N., Khusainova, M. A., Uzokov, J. B., & Makhmudova, K. D.
(2023). Heart failure and the risk of hypoglycemia. Science and Education, 4(5),
222-231.
18. Khusainova, M. A., Toirov, D. R., Khaydarov, S. N., & Kamolova, D. D. (2023).
MORPHOFUNCTIONAL PARAMETERS OF THE HEART IN WOMEN
SUFFERING FROM ESSENTIAL ARTERIAL HYPERTENSION IN
POSTMENOPAUSE AND ON THE BACKGROUND OF
TREATMENT. Oriental renaissance: Innovative, educational, natural and social
sciences, 3(1), 322-330.
19. Khusainova, M. A., Khaydarov, S. N., Makhmudova, K. D., & Nayimov, A. S.
(2023). Prevalence of bronchiolitis in patients with Rheumatoid arthritis. Science
and Education, 4(5), 232-241.
20. Khusainova, M. A., Khaydarov, S. N., Makhmudova, K. D., & Ortikova, S. X.
(2023). Features of prevention of chronic kidney diseases and chronic heart
failure. Science and Education, 4(5), 242-250.
21. Khabibovna, Y. S., Alisherovna, K. M., Tashtemirovna, E. M. M., Totlibayevich,
Y. S., Nizamitdinovich, K. S., & Baxtiyorovich, U. J. (2023). DIAGNOSTIC
VALUE OF CYSTATIN C IN PATIENTS WITH HYPERTENSION AND
OBESITY. World Bulletin of Public Health, 22, 55-59.
22. Alisherovna, K. M., Akramovna, I. K., Bakhtiyorovich, U. J., Nizamitdinovich, K.
S., Jasurovna, J. S., Kairatovna, R. A., & Abdukholikovna, E. S. (2023).
Exacerbations of chronic obstructive pulmonary disease and coronary
atherosclerosis. Journal of new century innovations, 39(1), 176-178.
23. Alisherovna, K. M., Erkinovna, K. Z., Djamshedovna, K. D., & Nizamitdinovich,
K. S. (2023). QUALITY OF LIFE PATIENTS WITH
OSTEOARTHRITIS. Journal of new century innovations, 36(1), 164-175.
24. Alisherovna, K. M., Mansurovna, M. D., Erkinovna, N. D., Farxodovna, X. R.,
Toxirovna, M. M., Tolibovna, R. D., & Yorkinovna, E. N. (2024). ARTERIAL HYPERTENSION AND THYROID STATUS IN PATIENTS OF DIFFERENT
AGES. Ta'lim innovatsiyasi va integratsiyasi, 19(4), 122-129.
25. Alisherovna, K. M., Ismatullayevich, M. A., & Nuriddinovna, E. N. (2024).
FEATURES OF HEART FAILURE IN PATIENTS WITH CORONARY HEART
DISEASE AND THYROTOXICOSIS. Ta'lim innovatsiyasi va
integratsiyasi, 19(4), 52-61.
26. Alisherovna, K. M., Erkinovna, S. D., Duskobilovich, B. S., & Samandarovich, T.
H. (2024). ARTERIAL HYPERTENSION IN THYROTOXICOSIS AND
REMODELING OF THE LEFT VENTRICLE OF THE HEART. Ta'lim
innovatsiyasi va integratsiyasi, 19(4), 114-121.
27. Alisherovna, K. M., Yaxshiboyevich, U. M. R., & Yigitaliyevich, B. A. (2024).
EVALUATION OF A NATRIURETIC PEPTIDE TO OPTIMIZE THE
MANAGEMENT OF COMORBID PATIENTS WITH THYROTOXICOSIS
AND HEART FAILURE. Ta'lim innovatsiyasi va integratsiyasi, 19(4), 62-70.
28. Alisherovna, K. M., Habibulloyevna, I. M., & Voxidovna, R. F. (2024).
STRUCTURAL AND FUNCTIONAL FEATURES OF THE LEFT VENTRICLE
IN PATIENTS WITH HEART FAILUREIN ISCHEMIC HEART DISEASE AND
THYROTOXICOSIS. Ta'lim innovatsiyasi va integratsiyasi, 19(4), 71-81.
29. Alisherovna, K. M., Erkinovna, S. D., Yazdonkulovna, X. M., & Zafarovna, C. M.
M. (2024). ATRIAL FIBRILLATION IN THYROTOXICOSIS–
DETERMINANTS OF DEVELOPMENT AND CONSERVATION. Ta'lim
innovatsiyasi va integratsiyasi, 19(4), 103-113.
30. Alisherovna, K. M., Akramovna, I. K., & Kairatovna, R. A. (2024). THE
EFFECTIVENESS OF TREATMENT OF PATIENTS WITH
OSTEOARTHRITIS WITH CARDIOVASCULAR DISORDERS IN
METABOLIC SYNDROME. Ta'lim innovatsiyasi va integratsiyasi, 18(5), 223-
230.
